-$0.12
(-0.25%)
| Today's Open | $49.75 |
|---|---|
| Previous Close | $49.81 |
| Daily Range | $48.32 - $49.75 |
| 52-Week Range | $39.62 - $59.24 |
| Market Cap | $3.7B |
| P/E Ratio | -53.56 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 879,258 |
| Average Daily Volume | 1,033,932 |
| Current FY EPS | -$1.07 |
Sector
Healthcare
Industry
Drugs
Medivation, Inc. (MDVN) Description
A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies. Website: http://www.medivation.net/
News & Commentary
Astellas and Medivation Announce Submission of Application for Marketing Approval of Enzalutamide, a
Astellas, Medivation Announce Submission of Application for Marketing Approval of Enzalutamide in Ja
Astellas, Medivation Announce Submission of Application for Marketing Approval of Enzalutamide in JapanThe 8 Biggest Health Problems Americans Face
What health problems do Americans think are most significant? Some of the answers might be surprising.Dendreon: Picking Through the Carnage
First-quarter results for the prostate cancer drug maker were even uglier than anticipated.3 Horrendous Health-Care Stocks This Week
These three health-care stocks were party-poopers this week as investors celebrated the market hitting all-time highs, yet again.MDVN's Top Competitors
(-1.91%)
(1.79%)
(-1.08%)
(0.64%)